<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Inspira Technologies Oxy Bhn Ltd — News on 6ix</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd</link>
<description>Latest news and press releases for Inspira Technologies Oxy Bhn Ltd on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 28 Apr 2026 12:51:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/inspira-technologies-oxy-bhn-ltd" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835830578dffbe2df0fc83b.webp</url>
<title>Inspira Technologies Oxy Bhn Ltd</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd</link>
</image>
<item>
<title>Inspira Technologies Secures Fully Paid $390,000 Purchase Order and Recurring Revenue Stream from Premier APAC University</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-technologies-secures-fully-paid-dollar390000-purchase-order-and-recurring-revenue-stream-from-premier-apac-university</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-technologies-secures-fully-paid-dollar390000-purchase-order-and-recurring-revenue-stream-from-premier-apac-university</guid>
<pubDate>Tue, 28 Apr 2026 12:51:00 GMT</pubDate>
<description>RA'ANANA, Israel, April 28, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies Oxy B.H.N. Ltd. (Nasdaq: IINN, IIINNW) ("Inspira" or the "Company"), today announced that it has received a $390,000 payment for an additive manufacturing electronics (“AME”) system purchase order, which also establishes an ongoing recurring revenue stream, from a premier technological research university in the Asia-Pacific region, widely recognized for its leading advancements in quantum computing and quantum information</description>
</item>
<item>
<title>Inspira Completes Commercial Deployment of its AME System at a Tier-1 U.S. Defense Entity</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-completes-commercial-deployment-of-its-ame-system-at-a-tier-1-us-defense-entity</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-completes-commercial-deployment-of-its-ame-system-at-a-tier-1-us-defense-entity</guid>
<pubDate>Thu, 16 Apr 2026 04:00:00 GMT</pubDate>
<description>RA'ANANA, Israel, April 16, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), today announced the</description>
</item>
<item>
<title>Inspira Technologies Appoints Yoav Rozanovich as Chief Business Officer to Drive Immediate Revenue Growth and Quantum Expansion</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-technologies-appoints-yoav-rozanovich-as-chief-business-officer-to-drive-immediate-revenue-growth-and-quantum-expansion</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-technologies-appoints-yoav-rozanovich-as-chief-business-officer-to-drive-immediate-revenue-growth-and-quantum-expansion</guid>
<pubDate>Tue, 14 Apr 2026 04:00:00 GMT</pubDate>
<description>RA'ANANA, Israel, April 14, 2026 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd (NASDAQ: IINN, IINNW) (“Inspira Technologies” or the “Company”) today</description>
</item>
<item>
<title>Inspira Begins AME Technology Implementation Process with One of the World's 10 Largest U.S. Based Companies</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-begins-ame-technology-implementation-process-with-one-of-the-worlds-10-largest-us-based-companies</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-begins-ame-technology-implementation-process-with-one-of-the-worlds-10-largest-us-based-companies</guid>
<pubDate>Mon, 13 Apr 2026 04:00:00 GMT</pubDate>
<description>RA'ANANA, Israel, April 13, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), today announced the</description>
</item>
<item>
<title>Inspira Enters Quantum Computing Sector, Targeting a Critical Connectivity Bottleneck with Newly Acquired AME Platform</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-enters-quantum-computing-sector-targeting-a-critical-connectivity-bottleneck-with-newly-acquired-ame-platform</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-enters-quantum-computing-sector-targeting-a-critical-connectivity-bottleneck-with-newly-acquired-ame-platform</guid>
<pubDate>Mon, 06 Apr 2026 04:00:00 GMT</pubDate>
<description>The Company is targeting a new 3D connectivity architecture for use in dilution cryostats, designed to overcome interconnect density limitations, reduce</description>
</item>
<item>
<title>Inspira Technologies Announces Acquisition of the AME Platform from Nano Dimension</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-technologies-announces-acquisition-of-the-ame-platform-from-nano-dimension</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-technologies-announces-acquisition-of-the-ame-platform-from-nano-dimension</guid>
<pubDate>Mon, 06 Apr 2026 04:00:00 GMT</pubDate>
<description>The transaction includes intellectual property, customer-related assets and commercial operations, positioning the Company for the next stage of its strategy</description>
</item>
<item>
<title>Inspira Technologies Terminates ATM and SEPA Equity Facilities to Prepare for Next Strategic Phase</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-technologies-terminates-atm-and-sepa-equity-facilities-to-prepare-for-next-strategic-phase</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-technologies-terminates-atm-and-sepa-equity-facilities-to-prepare-for-next-strategic-phase</guid>
<pubDate>Tue, 31 Mar 2026 04:00:00 GMT</pubDate>
<description>RA'ANANA, Israel, March 31, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ("Inspira" or the "Company"), a pioneer in</description>
</item>
<item>
<title>Inspira Technologies Reports Full Year 2025 Financial Results and Provides Business Updates</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-technologies-reports-full-year-2025-financial-results-and-provides-business-updates</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-technologies-reports-full-year-2025-financial-results-and-provides-business-updates</guid>
<pubDate>Thu, 26 Mar 2026 04:00:00 GMT</pubDate>
<description>Company Demonstrates Clinical Validation and Early Commercial Traction Toward 2026 Revenue Scale RA'ANANA, Israel, March 26, 2026 (GLOBE NEWSWIRE) -- Inspira™</description>
</item>
<item>
<title>Inspira Receives Nasdaq Notification Regarding Minimum Market Value Deficiency</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-receives-nasdaq-notification-regarding-minimum-market-value-deficiency</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-receives-nasdaq-notification-regarding-minimum-market-value-deficiency</guid>
<pubDate>Wed, 25 Feb 2026 21:10:00 GMT</pubDate>
<description>Ra’anana, Israel, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW) (“Inspira Technologies” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced that on February 19, 2026, it received written notice (the “Notice”) from The Nasdaq Stock Market (“Nasdaq”) advising the Company that it was not in compliance with Listing Rule 5550(b)(2) requiring companies listed on the Nasdaq Capital Market to maintain a mini</description>
</item>
<item>
<title>Inspira Expands U.S. Commercial Footprint: Deploys ART100 at a New Premier New York Academic Medical Center, Ranked Top 10 in New York State</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-expands-us-commercial-footprint-deploys-art100-at-a-new-premier-new-york-academic-medical-center-ranked-top-10-in-new-york-state</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-expands-us-commercial-footprint-deploys-art100-at-a-new-premier-new-york-academic-medical-center-ranked-top-10-in-new-york-state</guid>
<pubDate>Wed, 18 Feb 2026 13:32:00 GMT</pubDate>
<description>RA'ANANA, Israel, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW) (“Inspira Technologies” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced the deployment and initiation of a structured commercial evaluation of its U.S. Food and Drug Administration (“FDA”)-cleared INSPIRA™ ART100 system (the “ART100”) at a new and additional leading U.S. academic medical center. The partnering institution is a promin</description>
</item>
<item>
<title>Inspira Accelerates U.S. Commercial Strategy: FDA-Cleared ART100 Targets Market Adoption at AmSECT 2026 via Glo-Med Networks</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-accelerates-us-commercial-strategy-fda-cleared-art100-targets-market-adoption-at-amsect-2026-via-glo-med-networks</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-accelerates-us-commercial-strategy-fda-cleared-art100-targets-market-adoption-at-amsect-2026-via-glo-med-networks</guid>
<pubDate>Tue, 17 Feb 2026 13:00:00 GMT</pubDate>
<description>RA'ANANA, Israel, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW) (“Inspira Technologies,” “Inspira,” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced a strategic commercial showcase of its U.S. Food and Drug Administration (“FDA”)-cleared INSPIRA™ ART100 system. The system will be featured at the American Society of Extracorporeal Technology (AmSECT) 64th International Conference, taking place Marc</description>
</item>
<item>
<title>Inspira Technologies Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Requirement</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-technologies-announces-receipt-nasdaq-210100142</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-technologies-announces-receipt-nasdaq-210100142</guid>
<pubDate>Thu, 12 Feb 2026 21:01:00 GMT</pubDate>
<description>RA'ANANA, Israel, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN,IINNW) (“Inspira Technologies” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced that it received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on February 9, 2026, notifying the Company that it is not currently in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rul</description>
</item>
<item>
<title>Inspira Secures Vendor Approval from $12 Billion Revenue HMO (World’s 2nd Largest), Enabling Immediate ART100 Deployment</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-secures-vendor-approval-12-120000069</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-secures-vendor-approval-12-120000069</guid>
<pubDate>Mon, 09 Feb 2026 12:00:00 GMT</pubDate>
<description>RA'ANANA, Israel, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN,IINNW) (“Inspira Technologies” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced a pivotal commercial advancement. The Company has received official approval from the Medical Equipment Committee of Clalit Health Services (“Clalit”), recognized as the second-largest integrated Health Maintenance Organization (HMO) globally. The approval enables</description>
</item>
<item>
<title>Inspira Announces Pricing of $4.75 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market under Nasdaq Rules</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-announces-pricing-4-75-130000307</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-announces-pricing-4-75-130000307</guid>
<pubDate>Thu, 05 Feb 2026 13:00:00 GMT</pubDate>
<description>RA'ANANA, Israel, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW) ("Inspira," “Inspira Technologies,” or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that it has entered into a definitive agreement with a single healthcare-focused, institutional investor for a registered direct offering priced at-the-market under Nasdaq Rules of an aggregate of 6,785,715 ordinary shares (or ordinary share equivalen</description>
</item>
<item>
<title>Inspira Technologies Validates Next-Gen Standalone HYLA™ Blood Sensor with Clinical-Grade Accuracy, Targeting $48 Billion Heart-Lung Surgery Market</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-technologies-validates-next-gen-142200819</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-technologies-validates-next-gen-142200819</guid>
<pubDate>Tue, 03 Feb 2026 14:22:00 GMT</pubDate>
<description>Company’s validation confirms 94.2% accuracy for blood pCO₂ measurement, pivot to standalone configuration opens immediate commercial pathway to global installed base of heart-lung machines and extracorporeal proceduresRA'ANANA, Israel, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW) (“Inspira Technologies” or the “Company”), a pioneer in innovative life-support and diagnostic technologies, today announced the successful validation in the Company’s a</description>
</item>
<item>
<title>ART100 Becomes Inspira’s First System to Complete Clinical Evaluation and Enters Budgeted Procurement at Top U.S. Medical Center</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/art100-becomes-inspira-first-system-133000001</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/art100-becomes-inspira-first-system-133000001</guid>
<pubDate>Thu, 29 Jan 2026 13:30:00 GMT</pubDate>
<description>RA'ANANA, Israel, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN, IINNW) ("Inspira," "Inspira Technologies," or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that its U.S. Food and Drug Administration (the “FDA”)-cleared INSPIRA™ ART100 system has completed its full clinical evaluation and advanced to a budgeted procurement execution process at a leading U.S. academic medical center, ranked among the top h</description>
</item>
<item>
<title>Inspira Advances to Final Governmental Budgetary Validation Procedures for Previously Announced Binding Purchase Orders</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-advances-final-governmental-budgetary-135000300</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-advances-final-governmental-budgetary-135000300</guid>
<pubDate>Wed, 21 Jan 2026 13:50:00 GMT</pubDate>
<description>RA'ANANA, Israel, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN,IINNW) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today provided an update highlighting significant progress in the execution of its previously announced binding purchase orders. The Company has received a formal notification from its distribution partner that the $22.5 million and $27 million binding purchase orders, originally announced on</description>
</item>
<item>
<title>Inspira Outlines Strategic Vision and Transaction Framework for Breast Cancer Liquid Biopsy Expansion</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-outlines-strategic-vision-transaction-135000717</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-outlines-strategic-vision-transaction-135000717</guid>
<pubDate>Thu, 08 Jan 2026 13:50:00 GMT</pubDate>
<description>Company details contemplated transaction structure designed to preserve shareholder value and enable future dividend distributions from core technologiesRA'ANANA, Israel, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," "Inspira Technologies," or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today outlines its strategic vision and proposed transaction framework for its planned expansion into liquid biopsy diagn</description>
</item>
<item>
<title>CORRECTION – Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/correction-inspira-signs-term-sheet-154600266</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/correction-inspira-signs-term-sheet-154600266</guid>
<pubDate>Mon, 05 Jan 2026 15:46:00 GMT</pubDate>
<description>All-share acquisition positions Inspira to expand into a multi-billion dollar diagnostics market with a development-ready innovative technology; transaction structured to include significant protections for existing shareholders of Inspira relating to its existing technologiesRA'ANANA, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced it has</description>
</item>
<item>
<title>Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation</title>
<link>https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-signs-term-sheet-acquisition-143000802</link>
<guid isPermaLink="true">https://6ix.com/company/inspira-technologies-oxy-bhn-ltd/news/inspira-signs-term-sheet-acquisition-143000802</guid>
<pubDate>Mon, 05 Jan 2026 14:30:00 GMT</pubDate>
<description>All-share acquisition positions Inspira to expand into a multi-billion dollar diagnostics market with a development-ready innovative technology; transaction structured to include significant protections for existing shareholders of Inspira relating to its existing technologiesRA'ANANA, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced it has</description>
</item>
</channel>
</rss>